Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study

Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study

There is limited data on the effect of the novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) on pediatric rheumatology. We examined the prevalence of antibodies against SARS-CoV-2 in children with juvenile idiopathic arthritis (JIA) and a neg...

Full description

Bibliographic Details
Main Authors: Violetta Opoka-Winiarska, Ewelina Grywalska, Izabela Korona-Glowniak, Katarzyna Matuska, Anna Malm, Jacek Roliński
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
juvenile idiopathic arthritis
disease-modifying antirheumatic drugs
SARS-CoV-2
Online Access:https://www.mdpi.com/2077-0383/10/8/1771

Similar Items

Similar Items